{
    "organizations": [],
    "uuid": "0852edbddc6a81e0c463302bcec6a0a24fce9708",
    "author": "",
    "url": "https://www.reuters.com/article/brief-pfizer-has-not-received-acceptable/brief-pfizer-has-not-received-acceptable-offer-for-consumer-health-idUSL1N1S80LS",
    "ord_in_thread": 0,
    "title": "BRIEF-Pfizer Has Not Received Acceptable Offer For Consumer Health",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "May 1, 2018 / 3:27 PM / Updated 4 minutes ago BRIEF-Pfizer Has Not Received Acceptable Offer For Consumer Health Reuters Staff 1 Min Read\nMay 1 (Reuters) - Pfizer Inc:\n* PFIZER CEO SAYS HAS NOT YET RECEIVED AN ACCEPTABLE OFFER FOR CONSUMER HEALTH BUSINESS, MAY DECIDE TO RETAIN IT\n* PFIZER CEO SAYS THROUGH 2022 HAS 15 POTENTIAL BLOCKBUSTER DRUGS IN DEVELOPMENTAL PIPELINE\n* PFIZER CEO SAYS DONâ€™T SEE NEED FOR TRANSFORMATIVE DEAL OR SEE ONE AT APPROPRIATE VALUE Source text for Eikon: Further company coverage: (Reporting By Bill Berkrot)",
    "published": "2018-05-01T18:23:00.000+03:00",
    "crawled": "2018-05-01T18:42:14.007+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "may",
        "pm",
        "updated",
        "minute",
        "ago",
        "received",
        "acceptable",
        "offer",
        "consumer",
        "health",
        "reuters",
        "staff",
        "min",
        "read",
        "may",
        "reuters",
        "pfizer",
        "inc",
        "pfizer",
        "ceo",
        "say",
        "yet",
        "received",
        "acceptable",
        "offer",
        "consumer",
        "health",
        "business",
        "may",
        "decide",
        "retain",
        "pfizer",
        "ceo",
        "say",
        "potential",
        "blockbuster",
        "drug",
        "developmental",
        "pipeline",
        "pfizer",
        "ceo",
        "say",
        "see",
        "need",
        "transformative",
        "deal",
        "see",
        "one",
        "appropriate",
        "value",
        "source",
        "text",
        "eikon",
        "company",
        "coverage",
        "reporting",
        "bill",
        "berkrot"
    ]
}